Nexo Therapeutics
Joe Patel is currently the VP Head of Discovery at nexo therapeutics, having previously worked as the Vice President Structural Biology at Treeline Biosciences and Senior Director Biochemistry, Biophysics & Crystallography at C4 Therapeutics, Inc. At C4 Therapeutics, Joe built a talented team of structural biologists focused on driving the design of small molecule therapeutics. Joe also has experience as a Team Leader FBLG Chemistry at AstraZeneca and as a Senior Research Associate at Astex Pharmaceuticals. Joe holds a Ph.D. in X-ray Crystallography from the University of Cambridge and a Bachelor of Science in Biochemistry from Imperial College London.
Nexo Therapeutics
Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.